{
    "title": "109_hr4103",
    "content": "SECTION 1. SHORT TITLE; TABLE OF CONTENTS.\n\n    (a) Short Title.--This Act may be cited as the ``Medicare Advantage \nand Prescription Drug Accountability Act of 2005''.\n    (b) Table of Contents.--The table of contents of this Act is as \nfollows:\n\nSec. 1. Short title; table of contents.\nSec. 2. Requirement for reasonable return of benefits.\nSec. 3. Financial transparency.\nSec. 4. Beneficiary sign-off.\nSec. 5. Annual accountability reports.\nSec. 6. Auditing of actuarial equivalency.\nSec. 7. Report comparing costs and benefits under Medicare Advantage \n                            plans, medicare supplemental policies, and \n                            fee-for-service medicare.\nSec. 8. Annual report on drug claim denials.\nSec. 9. Medicare Prescription Drug Ombudsman.\n\nSEC. 2. REQUIREMENT FOR REASONABLE RETURN OF BENEFITS.\n\n    (a) Medicare Advantage Plans.--Section 1857(e) of the Social \nSecurity Act (42 U.S.C. 1395w-27(e)) is amended by adding at the end \nthe following new paragraph:\n            ``(4) Negotiation for loss and administrative cost \n        ratios.--\n                    ``(A) In general.--The contract with an MA \n                organization under this part shall provide for the \n                following:\n                            ``(i) Minimum loss ratio.--Aggregate \n                        average benefits that are at least a minimum \n                        ratio of the aggregate average revenues \n                        collected under the contract.\n                            ``(ii) Maximum administrative cost ratio.--\n                        Aggregate average administrative costs that do \n                        not exceed a maximum ratio of the aggregate \n                        average revenues collected under the contract.\n                    ``(B) Establishment of ratios.--The ratios under \n                clauses (i) and (ii) of subparagraph (A) shall be \n                established by the Secretary. In establishing such \n                ratios, the Secretary shall take into account, at a \n                minimum, ratios typical of those--\n                            ``(i) under private health insurance plans;\n                            ``(ii) under parts A and B of this title; \n                        and\n                            ``(ii) under health benefits plans offered \n                        under chapter 89 of title 5, United States Code \n                        (relating to the Federal Employees Health \n                        Benefits Program).''.\n    (b) Audit of Administrative Costs and Compliance With the Federal \nAcquisition Regulation.--Section 1857(d)(2)(B) of such Act (42 U.S.C. \n1395w-27(d)(2)(B)) is amended--\n            (1) by striking ``or (ii)'' and inserting ``(ii)''; and\n            (2) by inserting before the period at the end the \n        following: ``, or (iii) to compliance with the requirements of \n        subsection (e)(4)(A) and the extent to which administrative \n        costs comply with the applicable requirements for such costs \n        under the Federal Acquisition Regulation''.\n    (c) Application to Prescription Drug Plans.--The amendments made by \nsubsections (a) and (b) apply, pursuant to section 1860D-12(b)(3) of \nthe Social Security Act (42 U.S.C. 1395w-112(b)(3)), to contracts with \nprescription drug sponsors under part D of title XVIII of such Act.\n    (d) Effective Date.--The amendments made by this section shall \napply for contract years beginning after the date of the enactment of \nthis Act.\n\nSEC. 3. FINANCIAL TRANSPARENCY.\n\n    (a) Medicare Advantage Plans.--Section 1851(d) of the Social \nSecurity Act (42 U.S.C. 1395w-21(d)) is amended by adding at the end \nthe following new paragraph:\n            ``(8) Financial transparency.--\n                    ``(A) In general.--Each MA organization shall \n                provide annually to the Secretary (in a form and manner \n                specified by the Secretary), with respect to each MA \n                plan it offers and not later than 3 months after the \n                end of each contract year, information describing the \n                organization's compliance with the requirements of \n                section 1857(e)(4) and a functional listing of the \n                organization's administrative costs (by category of \n                such costs, including, at a minimum, marketing costs \n                and claims processing costs), profits, and investment \n                income (as defined by the Secretary), as a ratio of \n                aggregate average revenues collected under the contract \n                for that year.\n                    ``(B) Publication.--The Secretary shall publish the \n                information provided under subparagraph (A) for each MA \n                plan.''.\n    (b) Conforming Application to Prescription Drug Plans.--Section \n1860D-11(b)(2) of the Social Security Act 1395w-111(b)(2)) is amended \nby redesignating subparagraph (F) as subparagraph (G) and by inserting \nafter subparagraph (E) the following new subparagraph:\n                    ``(F) Periodic auditing.--Information with respect \n                to the prescription drug plan of the type described in \n                section 1851(d)(8) with respect to an MA plan.''.\n    (c) Effective Date.--The amendments made by this section shall \napply to reporting of information for contract years to which the \namendments made by section 2 apply.\n\nSEC. 4. BENEFICIARY SIGN-OFF.\n\n    (a) Medicare Advantage Plans.--Section 1851(c)(2) of the Social \nSecurity Act (42 U.S.C. 1395w-21(c)(2)) is amended by adding at the end \nthe following new subparagraph:\n                    ``(C) Beneficiary sign-off in election process.--An \n                election to enroll with an MA plan shall not be \n                effective unless the election form is signed by the \n                individual and specifically acknowledges each of the \n                following:\n                            ``(i) The premiums, cost-sharing \n                        requirements, and benefits under the plan may \n                        change at the beginning of each 12-month \n                        contract period.\n                            ``(ii) The individual may lose coverage of \n                        the individual's physician or other provider at \n                        the beginning of each such period.\n                            ``(iii) The plan may be terminated at the \n                        beginning of any such period.\n                            ``(iv) Premiums and benefits under the plan \n                        may vary based on the county or other MA area \n                        in which the plan is offered.''.\n    (b) Application to Prescription Drug Plans.--The amendment made by \nsubsection (a) applies, pursuant to section 1860D-1(b)(1)(B)(ii) of the \nSocial Security Act (42 U.S.C. 1395w-101(b)(1)(B)(ii)), to prescription \ndrug plans under part D of title XVIII of such Act.\n    (c) Effective Date.--The amendment made by subsection (a) shall \napply to elections made on or after the date specified by the Secretary \nof Health and Human Services, but in no case later than 60 days after \nthe date of the enactment of this Act.\n\nSEC. 5. ANNUAL ACCOUNTABILITY REPORTS.\n\n    (a) Medicare Advantage Accountability Report.--Section 1856 of the \nSocial Security Act (42 U.S.C. 1395w-26) is amended--\n            (1) by amending the heading to read as follows:\n\n   ``establishment of standards; annual accountability report''; and\n\n            (2) by adding at the end the following new subsection:\n    ``(c) Annual Accountability Report.--\n            ``(1) In general.--The Secretary shall compile, and \n        transmit to Congress, at the end of each year (beginning with \n        2005), an annual Medicare Advantage accountability report.\n            ``(2) Contents.--Each annual accountability report shall \n        include the following:\n                    ``(A) A detailed analysis of geographic variation \n                in cost-sharing and premiums among MA plans.\n                    ``(B) A comparison of the use of amounts paid to MA \n                plans for benefit payments, administrative costs, and \n                profits with the amounts expended under the fee-for-\n                service programs under parts A and B for benefit \n                payments and administrative expenses.\n                    ``(C) Recommendations for legislative changes to \n                the Medicare Advantage program, or the fee-for-service \n                programs under parts A and B, to assure that medicare \n                beneficiaries under both programs have access to \n                comparable benefits at comparable cost and that \n                Government subsidies under the two programs are \n                equivalent.\n                    ``(D) The results of audits conducted under section \n                1857(d) and enforcement actions taken in response to \n                findings of inappropriate expenditures of funds under \n                this part.''.\n    (b) Prescription Drug Accountability Report.--Section 1860D-12 of \nsuch Act (42 U.S.C. 1395w-112) is amended by adding at the end the \nfollowing new subsection:\n    ``(h) Annual Accountability Report.--\n            ``(1) In general.--The Secretary shall compile, and \n        transmit to Congress, at the end of each year (beginning with \n        2006), an annual prescription drug accountability report.\n            ``(2) Contents.--Each annual accountability report shall \n        include the same types of information (as specified by the \n        Secretary) with respect to prescription drug plans as are \n        provided under subparagraphs (A), (B), and (D) of section \n        1856(c)(2) with respect to MA plans.''.\n\nSEC. 6. AUDITING OF ACTUARIAL EQUIVALENCY.\n\n    (a) Medicare Advantage Plans.--Section 1854(a)(5) of the Social \nSecurity Act (42 U.S.C. 1395w-24(a)(5)) is amended by adding at the end \nthe following new subparagraph:\n                    ``(B) Periodic audits of actuarial equivalency \n                determinations.--In the case of MA plans that provide \n                for an actuarially equivalent level of benefits under \n                this part, the Inspector General of the Department of \n                Health and Human Services shall periodically audit a \n                representative sample of the determinations made by the \n                Secretary regarding such actuarial equivalency to \n                ensure that the Secretary is only approving plans with \n                benefits that are actuarially equivalent.''.\n    (b) Application to Prescription Drug Plans.--Section 1860D-11(e) of \nthe Social Security Act (42 U.S.C. 1395w-111(e)) is amended by adding \nat the end the following new paragraph:\n            ``(3) Periodic auditing of actuarial equivalency \n        determinations.--The provisions of section 1854(a)(5)(B) shall \n        apply with respect to determinations of actuarial equivalence \n        of benefits under prescription drug plans in the same manner as \n        they apply to determinations of actuarial equivalence of \n        benefits under MA plans.''.\n\nSEC. 7. REPORT COMPARING COSTS AND BENEFITS UNDER MEDICARE ADVANTAGE \n              PLANS, MEDICARE SUPPLEMENTAL POLICIES, AND FEE-FOR-\n              SERVICE MEDICARE.\n\n    Not later than 1 year after the date of the enactment of this Act, \nthe Secretary of Health and Human Services shall submit to Congress a \nreport that compares the average benefit payments, administrative \ncosts, profits, and investment income (expressed as a percentage of \nrevenues collected) for MA plans with such average for the fee-for-\nservice programs under parts A and B and for group and individual \nmedicare supplemental policies.\n\nSEC. 8. ANNUAL REPORT ON DRUG CLAIM DENIALS.\n\n    Section 1860D-4(h) of the Social Security Act (42 U.S.C. 1395w-\n104(h)) is amended by adding at the end the following new paragraph:\n            ``(4) Annual report on drug claims rejections and reversals \n        on appeal.--Each PDP sponsor with respect to a prescription \n        drug plan, and each MA organization with respect to an MA-PD \n        plan, shall annually report to the Inspector General of the \n        Department of Health and Human Services on the following:\n                    ``(A)(i) The percentage of claims for prescription \n                drugs under the plan that are initially denied.\n                    ``(ii) The percentage of such claim denials that \n                are appealed.\n                    ``(iii) The percentage of such appealed claim \n                denials that are reversed upon appeal.\n                    ``(B) The volume of such claims denials that are \n                based on--\n                            ``(i) a medical necessity determination;\n                            ``(ii) the drug not being on a formulary; \n                        and\n                            ``(iii) other reasons.''.\n\nSEC. 9. MEDICARE PRESCRIPTION DRUG OMBUDSMAN.\n\n    Section 1808 of the Social Security Act (42 U.S.C. 1395b-9) is \namended by adding at the end the following new subsection:\n    ``(d) Medicare Prescription Drug Ombudsman.--\n            ``(1) In general.--The Secretary shall appoint within the \n        Department of Health and Human Services a Medicare Prescription \n        Drug Ombudsman who shall have expertise and experience in the \n        fields of health care and education of (and assistance to) \n        individuals entitled to benefits under this title with respect \n        to prescription drug coverage under part D of this title.\n            ``(2) Duties.--The Medicare Prescription Drug Ombudsman \n        shall--\n                    ``(A) receive complaints, grievances, and requests \n                for information submitted by individuals entitled to \n                benefits under part D;\n                    ``(B) provide assistance with respect to \n                complaints, grievances, and requests referred to in \n                subparagraph (A), including--\n                            ``(i) assistance in collecting relevant \n                        information for such individuals, to seek an \n                        appeal of a decision or determination made by a \n                        PDP sponsor or MA organization;\n                            ``(ii) assistance to such individuals with \n                        any problems arising from disenrollment from a \n                        PDP under part C or an MA-PD plan under part D;\n                    ``(C) provide assistance to beneficiaries in \n                relation to State medicaid programs under title XIX and \n                drug manufacturers in accessing medically necessary \n                drugs that are excluded from coverage under part D; and\n                    ``(D) submit annual reports to Congress and the \n                Secretary that describe the activities of the Office \n                and that include such recommendations for improvement \n                in the administration of part D of this title as the \n                Ombudsman determines appropriate.\n        The annual report under subparagraph (D) in 2007 and 2009 shall \n        include information on the number of cases described in \n        subparagraph (C) that are handled and the success rates in \n        finding alternative sources of coverage.''."
}